The Molecular Mechanisms of Action of Photobiomodulation Against Neurodegenerative Diseases: A Systematic Review
Bathini M, Raghushaker CR, Mahato KK
Cellular and molecular neurobiology · 75 citas
Cómo se estudió
- Diseño
- Revisión sistemática (indexado por PubMed)
- Estudiado en
- Animales
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Gobierno
- Department of Science and Technology, Ministry of Science and Technology, India
- Gobierno
- Indian Council of Medical Research
- Gobierno
- Technology Information, Forecasting and Assessment Council
- Universidad u hospital
- Manipal Academy of Higher Education, Manipal
Según 4 financiadores declarados y la declaración de financiación del texto completo.
Publicación
- Publicado
- 2020-12-10 · Cell Mol Neurobiol · vol. 42 · número 4 · págs. 955–971
- Editorial
- Springer Science+Business Media
- Citado
- 113 citas · más que el 90% de estudios similares · 2.0× el promedio de su campo
- Referencias
- 112 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY
- Áreas de investigación
- Laser Applications in Dentistry and Medicine · Medical and Biological Ozone Research · Hydrogen's biological and therapeutic effects
- Palabras clave
- Neurodegeneration, Neuroscience, MAPK/ERK pathway, Disease, Signal transduction, Protein kinase B, Protein kinase A, Kinase, Bioinformatics, Biology, Inflammation, Medicine, Neurotrophic factors, Cell biology, Immunology, Genetics, Receptor, Pathology
- MeSH
- mitochondria, humans, neurodegenerative diseases, mitogen-activated protein kinases, cell survival, low-level light therapy
3 autores
- Mayukha Bathini🇮🇳Manipal Academy of Higher Education
- Chandavalli Ramappa Raghushaker🇮🇳Manipal Academy of Higher Education
- Krishna Kishore Mahato🇮🇳 · autor de correspondenciaManipal Academy of Higher Education
Resumen
El texto original del estudio, en el idioma en que se publicó.
Neurodegenerative diseases might be slow but relentless, as we continue to fail in treating or delaying their progression. Given the complexity in the pathogenesis of these diseases, a broad-acting approach like photobiomodulation can prove promising. Photobiomodulation (PBM) uses red and infrared light for therapeutic benefits, working by stimulating growth and proliferation. The implications of photobiomodulation have been studied in several neurodegenerative disease models. It has been shown to improve cell survival, decrease apoptosis, alleviate oxidative stress, suppress inflammation, and rescue mitochondrial function. In in vivo models, it has reportedly preserved motor and cognitive skills. Beyond mitochondrial stimulation, the molecular mechanisms by which photobiomodulation protects against neurodegeneration have not been very well studied. This review has systematically been undertaken to study the effects of photobiomodulation at a molecular level and identify the different biochemical pathways and molecular changes in the process. The data showed the involvement of pathways like extracellular signal-regulated kinase (ERK), mitogen-activated protein kinase (MAPK), and protein kinase B (Akt). In addition, the expression of several genes and proteins playing different roles in the disease mechanisms was found to be influenced by PBM, such as neurotrophic factors and secretases. Studying the literature indicated that PBM can be translated to a potential therapeutic tool, acting through a spectrum of mechanisms that work together to decelerate disease progression in the organism, which is difficult to achieve through pharmacological interventions.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.